Literature DB >> 21706178

Transvaginal mesh for prolapse repair: what is all the controversy about?

Farzeen Firoozi1.   

Abstract

The use of synthetic mesh for the management of pelvic organ prolapse has been embroiled in a contentious debate over the past decade, with only more partisanship among physicians strictly against its use versus those pelvic surgeons who believe it to be a useful tool in their armamentarium. At the heart of the controversy lies the concern, by its detractors, for complications related to mesh use outweighing the as yet not rigorously tested benefit of augmenting repairs with mesh. This article discusses, in detail, the current literature supporting the use of mesh in the management of pelvic organ prolapse repair. The rising concern for complications, both simple and complex, will be addressed. This review aims to narrow the divide between physicians and to address their discordant beliefs by objectively reporting the most up-to-date data on biologic and synthetic mesh use in pelvic organ prolapse repair. © Springer Science+Business Media, LLC 2011

Mesh:

Year:  2011        PMID: 21706178     DOI: 10.1007/s11934-011-0205-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  15 in total

1.  Rectocele repair: a randomized trial of three surgical techniques including graft augmentation.

Authors:  Marie Fidela R Paraiso; Matthew D Barber; Tristi W Muir; Mark D Walters
Journal:  Am J Obstet Gynecol       Date:  2006-12       Impact factor: 8.661

2.  Transvaginal mesh for cystocele repair.

Authors:  Howard B Goldman; Mary P Fitzgerald
Journal:  J Urol       Date:  2009-12-14       Impact factor: 7.450

3.  Anatomic outcomes of vaginal mesh procedure (Prolift) compared with uterosacral ligament suspension and abdominal sacrocolpopexy for pelvic organ prolapse: a Fellows' Pelvic Research Network study.

Authors:  Tatiana V D Sanses; Azin Shahryarinejad; Stephanie Molden; Kay A Hoskey; Shameem Abbasy; Danielle Patterson; Emily K Saks; Emily E Weber LeBrun; Tondalaya L Gamble; Virginia G King; Aimee L Nguyen; Husam Abed; Stephen B Young
Journal:  Am J Obstet Gynecol       Date:  2009-08-28       Impact factor: 8.661

4.  The efficacy of Marlex mesh in the repair of severe, recurrent vaginal prolapse of the anterior midvaginal wall.

Authors:  T M Julian
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

5.  Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles.

Authors:  P K Sand; S Koduri; R W Lobel; H A Winkler; J Tomezsko; P J Culligan; R Goldberg
Journal:  Am J Obstet Gynecol       Date:  2001-06       Impact factor: 8.661

6.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

7.  Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: a randomized trial.

Authors:  Christopher F Maher; Benjamin Feiner; Eva M DeCuyper; Cathy J Nichlos; Kacey V Hickey; Peter O'Rourke
Journal:  Am J Obstet Gynecol       Date:  2011-04       Impact factor: 8.661

8.  Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial.

Authors:  Reijo Hiltunen; Kari Nieminen; Teuvo Takala; Eila Heiskanen; Mauri Merikari; Kirsti Niemi; Pentti K Heinonen
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661

9.  Outcome after anterior vaginal prolapse repair: a randomized controlled trial.

Authors:  John N Nguyen; Raoul J Burchette
Journal:  Obstet Gynecol       Date:  2008-04       Impact factor: 7.661

10.  Transvaginal excision of mesh erosion involving the bladder after mesh placement using a prolapse kit: a novel technique.

Authors:  Farzeen Firoozi; Howard B Goldman
Journal:  Urology       Date:  2009-11-13       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.